145. West syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 43 / Drugs : 52 - (DrugBank : 15) / Drug target genes : 28 - Drug target pathways : 26
West syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 145 | West syndrome |
| 2 | Amyotrophic lateral sclerosis |
| 6 | Parkinson disease |
| 13 | Multiple sclerosis/Neuromyelitis optica |
| 144 | Lennox-Gastaut syndrome |
| 8 | Huntington disease |
| 46 | Malignant rheumatoid arthritis |
| 140 | Dorabe syndrome |
| 97 | Ulcerative colitis |
| 206 | Fragile X syndrome |
| 158 | Tuberous sclerosis |
| 205 | Fragile X syndrome related disease |
| 156 | Rett syndrome |
| 152 | PCDH19 related syndrome |
| 193 | Prader-Willi syndrome |
| 298 | Hereditary pancreatitis |
| 98 | Eosinophilic gastrointestinal disease |
| 18 | Spinocerebellar degeneration |
| 201 | Angelman syndrome |
| 36 | Epidermolysis bullosa |
| 3 | Spinal muscular atrophy |
| 96 | Crohn disease |
| 75 | Cushing disease |
| 272 | Fibrodysplasia ossificans progressiva |
| 84 | Sarcoidosis |
| 22 | Moyamoya disease |
| 296 | Biliary atresia |
| 155 | Acquired aphasia with convulsive disorder |
| 21 | Mitochondrial disease |
| 231 | Alpha-1-antitrypsin deficiency |
| 17 | Multiple system atrophy |
| 5 | Progressive supranuclear palsy |
| 70 | Spinal stenosis |
| 34 | Neurofibromatosis |
| 149 | Hemiconvulsion hemiplegia epilepsy syndrome |
| 49 | Systemic lupus erythematosus |
| 202 | Smith-Magenis syndrome |
| 220 | Rapidly progressive glomerulonephritis |
| 30 | Distal myopathy |